{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:45:38Z","timestamp":1789933538284,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1353,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/j.1524-4733.2009.00635.x","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T16:34:13Z","timestamp":1257525253000},"page":"S85-S88","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S3","title":["Cost-Effectiveness Study Comparing Imatinib with Interferon-\u03b1 for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Health-Care System Perspective (CPHSP)"],"prefix":"10.1016","volume":"12","author":[{"given":"Zi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2009.00635.x_bib10","series-title":"Cancer Facts and Figures 2007","author":"American Cancer Society","year":"2007"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4065\/81.7.973","article-title":"Chronic myeloid leukemia: diagnosis and treatment","volume":"81","author":"Quintas-Cardama","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1188\/05.CJON.535-538","article-title":"Chronic myelogenous leukemia","volume":"9","author":"D'Antonio","year":"2005","journal-title":"Clin J Oncol Nurs"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.286.8.895","article-title":"Chronic myelogenous leukemia","volume":"286","author":"Kalidas","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"NEJM"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2141.2001.02558.x","article-title":"Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory","volume":"113","author":"Holyoake","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib70","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib80","author":"National Comprehensive Cancer Network"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib90","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/cncr.20694","article-title":"Cost-effectiveness of imatinib versus interferon-\u03b1 plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia","volume":"101","author":"Reed","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00019053-200523050-00010","article-title":"Cost effectiveness of imatinib compared with interferon-\u03b1 or hydroxycarbamide for first-line treatment of chronic myeloid leukemia","volume":"23","author":"Dalziel","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib110","first-page":"472","article-title":"Pharmacoeconomic evaluation of imatinib in the treatment of chronic myeloid leukemia [in Chinese]","volume":"40","author":"Wang","year":"2005","journal-title":"Chin Pharma J"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00019053-200826050-00007","article-title":"Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"26","author":"Reed","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2009.00635.x_bib130","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood.V108.11.3314.3314","article-title":"Cost-effectiveness of imatinib versus interferon-\u03b1 in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective","volume":"108","author":"Mataveli","year":"2006","journal-title":"Blood"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510603488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510603488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T09:54:09Z","timestamp":1590227649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510603488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":13,"alternative-id":["S1098301510603488"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00635.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}